Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...

Haystack MRD test detects minimal residual disease in stage 2 colorectal cancer patients post-surgery, using circulating tumor DNA (ctDNA) for less invasive monitoring. The FDA's breakthrough device ...

Colonic stent placement as a bridge to surgery shows similar survival to emergency resection while reducing stoma rates in obstructive colorectal cancer.

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

Meta analysis in obese colorectal cancer patients found robotic assisted surgery modestly reduced hospital stay versus standard laparoscopy, with no significant differences in complications, ...

Regular exercise could help cancer patients live longer, new research suggests. The findings come from a study that randomly divided 889 colon cancer patients into two groups – one that adopted a ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...